{"id":"W7028370904","doi":"","title":"Enanta Pharmaceuticals Reports Financial Results for Its Fiscal Third Quarter Ended June 30, 2014 - NASDAQ (NASDAQ01) News","year":2014,"lang":"en","type":"other","venue":"","topic":"Ancient and Medieval Archaeology Studies","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Term (time); Revenue; Work (physics); Fiscal year","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005640344,0.0006323065,0.001017324,0.0002409733,0.0004159053,0.00005407159,0.0002772573,0.0004049398,0.00511705],"category_scores_gemma":[0.0003768248,0.0004447781,0.0003875186,0.00002712664,0.0007572304,0.00007498657,0.0002002807,0.0003666522,0.001453229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002874558,"about_ca_system_score_gemma":0.00009507455,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008712683,"about_ca_topic_score_gemma":0.006658677,"domain_scores_codex":[0.9968378,0.00009073158,0.0008754368,0.0009222957,0.0003825105,0.0008912554],"domain_scores_gemma":[0.998345,0.0002605454,0.0005476006,0.0004884431,0.0001481263,0.0002102498],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001888196,0.00008297398,0.00001942596,0.0001634487,0.0001585987,0.00003894811,0.003899134,6.037378e-8,0.00001108237,0.03085348,0.9641973,0.0003866678],"study_design_scores_gemma":[0.001413266,0.0002397491,0.00001099472,0.0001472216,0.0002200886,0.00001156361,0.0004132382,0.00001781291,0.0001007092,0.001292366,0.9955142,0.0006188293],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.00003785586,0.001853119,0.0002521795,0.004328198,0.009282928,0.001260402,0.0003698641,0.0004241229,0.9821913],"genre_scores_gemma":[0.0008906703,0.0005789262,0.0001798021,0.002988395,0.008812462,0.0002207119,0.0002790719,0.0001796998,0.9858702],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.03131681,"threshold_uncertainty_score":0.9998004,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04140904497674174,"score_gpt":0.2923484160810949,"score_spread":0.2509393711043531,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}